Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FDA Suggests Alternatives for Complying With QS Requirements

  • Post author:Sam
  • Post published:July 6, 2018
  • Post category:The GMP Letter

The FDA put out a list of alternative ways to comply with quality system requirements for device combination products, making suggestions for design controls and quality system regulation exemptions. Source:…

Continue ReadingFDA Suggests Alternatives for Complying With QS Requirements

FDA Seeks Comment on Medical Device Software

  • Post author:Sam
  • Post published:June 7, 2018
  • Post category:The GMP Letter

The FDA invited stakeholder comments on how it should craft rules governing medical device software under the 21st Century Cures Act. Source: The GMP Letter

Continue ReadingFDA Seeks Comment on Medical Device Software

India Releases Guidance on Essential Safety and Performance Principles

  • Post author:Sam
  • Post published:June 7, 2018
  • Post category:The GMP Letter

India’s Drugs Controller General adopted essential principles for safety and performance of medical devices. Source: The GMP Letter

Continue ReadingIndia Releases Guidance on Essential Safety and Performance Principles

483 Roundup: FDA Flags Six Firms Over Design Controls, Data Integrity

  • Post author:Sam
  • Post published:June 7, 2018
  • Post category:The GMP Letter

The FDA issued 483s to six device facilities for a variety of deficiencies including design control procedures, data integrity, CAPAs and complaint handling. Source: The GMP Letter

Continue Reading483 Roundup: FDA Flags Six Firms Over Design Controls, Data Integrity

No Regulatory Changes for Australia’s Personalized and 3D Printed Devices

  • Post author:Sam
  • Post published:June 7, 2018
  • Post category:The GMP Letter

Australia’s Therapeutic Goods Administration released findings from a public consultation on proposed regulatory changes for personalized and 3D printed medical devices and said, based on the stakeholder feedback, it decided…

Continue ReadingNo Regulatory Changes for Australia’s Personalized and 3D Printed Devices

Canada Makes Additional Adjustments to MDSAP Program

  • Post author:Sam
  • Post published:June 7, 2018
  • Post category:The GMP Letter

Health Canada is making further reductions in audit times for its Medical Device Single Audit Program for smaller companies with lower-risk products. Source: The GMP Letter

Continue ReadingCanada Makes Additional Adjustments to MDSAP Program

FDA Rejects New Device Regulation for Third-Party Servicers

  • Post author:Sam
  • Post published:June 7, 2018
  • Post category:The GMP Letter

The FDA rejected a push to impose additional regulations on third-party servicers of medical devices, saying there is insufficient evidence to justify imposing new regulatory requirements. Source: The GMP Letter

Continue ReadingFDA Rejects New Device Regulation for Third-Party Servicers

FDA Moves to Improve Device Safety Through Competition Around Safer Design

  • Post author:Sam
  • Post published:June 7, 2018
  • Post category:The GMP Letter

FDA Commissioner Scott Gottlieb offered more perspective on new initiatives the agency is undertaking to improve medical device safety in remarks at the FDLI annual conference in Washington, D.C. Source:…

Continue ReadingFDA Moves to Improve Device Safety Through Competition Around Safer Design

TGA Conducts Product Safety Review of Ventilators

  • Post author:Sam
  • Post published:May 15, 2018
  • Post category:The GMP Letter

Australia’s Therapeutic Goods Administration plans to conduct a product safety review on ventilators used in high-care hospital settings for long-term therapy of intubated patients. Source: The GMP Letter

Continue ReadingTGA Conducts Product Safety Review of Ventilators

New Zealand Proposes Fee Hikes for Devices

  • Post author:Sam
  • Post published:May 15, 2018
  • Post category:The GMP Letter

New Zealand’s Medicines and Medical Devices Safety Authority is proposing fee increases for the majority of its services, including reviewing new devices and GMP inspections. Source: The GMP Letter

Continue ReadingNew Zealand Proposes Fee Hikes for Devices
  • Go to the previous page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.